Clinical Trial Update: ALG-055009 in Non-cirrhotic Adults With MASH (HERALD) [Phase 2]

View source ↗

Summary

Phase 2 trial update: ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis/nonalcoholic steatohepatitis (HERALD) has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis
• Nonalcoholic Steatohepatitis

Drugs mentioned

• ALG-055009

Snippet

Sponsor: Aligos Therapeutics | Conditions: NASH, MASH | Phase 2 | Status: COMPLETED